Erelzi

Indicated For

Rheumatoid arthritis, Psoriatic arthritis, Plaque psoriasis, Ankylosing spondylitis, Polyarticular juvenile idiopathic arthritis

About This Medication

# XPOSE Patient Support Program Patient Guide: How to Get Erelzi (etanercept-szzs) at Low or No Cost Erelzi (etanercept-szzs) is a biosimilar medication used to treat conditions like rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and ankylosing spondylitis. The **XPOSE Patient Support Program** from Sandoz helps eligible Canadian patients access Erelzi through services like insurance reimbursement assistance, treatment support, and product information[1][2]. ## About Erelzi and Why You Might Need Assistance **Erelzi** is an injectable biosimilar to Enbrel (reference product), meaning it has a similar efficacy and safety profile but may be more affordable[2]. It's typically prescribed for **moderately to severely active rheumatoid arthritis (RA)**, **polyarticular juvenile idiopathic arthritis (JIA)**, and **active ankylosing spondylitis (AS)**. Patients self-administer it subcutaneously, often as a 50 mg weekly injection (one 50 mg or two 25 mg doses)[2]. These biologic treatments can be expensive without proper support. The XPOSE program provides **health and product information**, **insurance reimbursement help**, and **treatment-related services** to make therapy easier[1]. Participation is voluntary and won't affect your medical care or insurance[1]. ## Who Qualifies for the XPOSE Program? The program is open to Canadian patients prescribed Erelzi by their healthcare provider. Your doctor must confirm the prescription matches the product guidelines and obtain your consent to share information[1][2]. No specific income thresholds are listed, suggesting broad eligibility focused on those needing support services rather than strict financial criteria[1]. A third-party administrator handles your data securely under privacy laws[1]. ## Income Eligibility Breakdown Detailed income limits are not specified in program materials. It appears the XPOSE program prioritizes prescription and consent over financial means, potentially aiding insured or underinsured patients with access hurdles. Here's a summary table: | Household Size | Income Threshold | FPL % | Notes | |----------------|------------------|-------|-------| | Individual | Not specified | N/A | Focus on prescription support[1] | | Couple | Not specified | N/A | Insurance assistance available[1] | | Family of 3 | Not specified | N/A | Voluntary enrollment[1] | | Family of 4 | Not specified | N/A | No impact on treatment[1] | Contact the program for personalized eligibility checks. ## Insurance Requirements Insurance details aren't explicitly outlined, but the program offers **reimbursement assistance** to navigate coverage[1]. It's designed for patients facing barriers, regardless of insurance status. Your doctor discusses this with you before enrollment[2]. Unlike U.S. programs excluding government insurance, XPOSE supports Canadian public/private plans[1][2]. ## Step-by-Step Application Process 1. **Talk to Your Doctor**: Discuss Erelzi suitability. They complete the enrollment form, specifying dosage (e.g., 50 mg SC weekly), treatment duration, and TB screening if needed[2]. 2. **Complete Consent**: Sign the patient consent section, agreeing to share info for services. Optional: Allow market research contact[1][2]. 3. **Submit via Phone**: Call **(844) 279-7673** to start. Fax option at 1-866-872-5771 for forms[2]. All sections must be filled; physician signs declaration[1][2]. 4. **Physician Approval**: Doctor confirms prescription per monograph and your consent[1]. 5. **Enrollment Confirmation**: Sandoz or administrators contact you for services[1]. No online application noted; phone is primary[2]. ## Timeline and Delivery Processing times aren't detailed, but expect prompt handling post-submission. Services include follow-up on adverse events or TB results[2]. Medication delivery isn't specified—likely via pharmacy with reimbursement aid. Nurses may assist with injection training if available through Sandoz support[7]. Refills require physician reauthorization[2]. ## Alternatives if Denied or Other Options If ineligible, consider **Enbrel (reference product)** as a biosimilar alternative[2]. Explore Sandoz's broader patient support or provincial programs. For U.S. patients, Sandoz One Source offers co-pay help, but XPOSE is Canada-focused[4][5]. Consult your doctor for switches. ## Disclaimer This guide is for informational purposes based on available materials as of 2026. Eligibility, terms, and services may change; contact **(844) 279-7673** for updates. Not medical advice—speak to your healthcare provider. Sandoz isn't liable for decisions based on this guide. Participation voluntary; opt-out anytime without impacting care[1]. (Word count: 912)

Program information last verified: March 30, 2026